26774-88-9,
(R)-2-Amino-2-(cyclohexa-1,4-dien-1-yl)acetic acid,
(R)-(-)-2-(2,5-Dihydrophenyl)glycine,
(R)-(-)-2-Amino-2-(cyclohexa-1,4-dienyl)acetic Acid,
UNII-451NQ27TG5,
MFCD00137746,
451NQ27TG5,
D-(-)-2-(2,5-Dihydrophenyl)glycine,
(R)-2-amino-2-(cyclohexa-1,4-dienyl)acetic acid,
(R)-alpha-Amino-1,4-cyclohexadiene-1-acetic acid,
2,5-Dihydrophenylglycine, D-,
(2R)-2-amino-2-cyclohexa-1,4-dienylacetic acid,
EINECS 247-999-1,
2-Amino-2-(cyclohexadien-1,4-yl)acetic acid,
AC1LOQXH,
D-cyclohexadienylglycine,
D-2,5-Dihydrophenylglycin,
AC1Q4U6Z,
(R)-alpha-Aminocyclohexa-1,4-diene-1-acetic acid,
(R)-2,5-dihydrophenylglycine,
D-cyclohexa-1,4-dienylglycine,
CHEMBL4091926,
SCHEMBL11298974,
CTK3J6958,
(-)-2,5-Dihydro-D-phenylglycine,
ZINC4262033,
ANW-42987,
CD-455,
SBB058321,
(R)-2-(1,4-Cyclohexadienyl)glycine,
AKOS006237844,
RTR-012079,
KS-000015Q5,
AJ-49833,
AS-12187,
SC-13751,
(-)-2,5-Dihydro-D-phenylglycine, 97%,
2-(1,4-cyclohexanedien-1-yl)-D-glycine,
TR-012079,
D2539,
FT-0624333,
ST24026405,
ST50307293,
(2R)-Amino(1,4-cyclohexadien-1-yl)acetic acid,
(R)-|A-Amino-1,4-cyclohexadiene-1-acetic acid,
(R)-(-)-2-(2,5-Dihydrophenyl)glycine, 98%,
W-107154,
(2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetic acid,
(R)-alpha-Amino-1-(1,4-cyclohexadienyl)acetic acid,
BRD-K45497328-001-01-3,
I14-45756,
(2R)-2-amino-2-(cyclohexa-1,4-dien-1-yl)acetic acid,
(R)-? inverted exclamation markA-Amino-1,4-cyclohexadien-1-yl-essigsaeure,
Cyclohexa-1,4-dienylglycine, European Pharmacopoeia (EP) Reference Standard,
- -2- glycine,
2-amino-2- aceticacid,
D-(-)-2,5-Dihydrophenylglycine,
C8H11NO2,
C8-H11-N-O2,
NSC268228,
CID1268102,
20763-30-8,